Global biotechnology leader CSL (ASX:CSL; USOTC:CSLLY) and self-amplifying messenger RNA (sa-mRNA) pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...Sep 13, 2024, 08:15 ET Japan's Ministry of Health, Labor and Welfare Approves CSL and Arcturus Therapeutics' Updated Self-amplifying mRNA...
CSL Behring AG, Berne, Switzerland, a wholly-owned subsidiary of global biotechnology leader CSL Limited (ASX: CSL; USOTC: CSLLY), today published the offer prospectus regarding its public tender offer for all publicly held registered shares of Vifor Pharma Ltd. (SIX:VIFN; ISIN:CH0364749348)...
We have profited handsomely from the ownership, on behalf of our investors, of CSL (ASX:CSL) in The Montgomery Fund and The Montgomery [Private] Fund, so we are cheering it along as it grows daily in market value. Australian biotech company CSL Limited was founded in 1916 and researches,...